Figure 4.

miR-363 and sp1 serve as diagnostic biomarkers in GC. A, miR-363 expression between GC and adjacent tissues assessed by RT-qPCR (*p < 0.05 by the paired t test); B, Person’s correlation analysis of circ0005654 and miR-363 expression in GC tissues; C, the diagnostic effect of miR-363 evaluated by ROC curves using the Wilson/Brown analysis; D, the survival curves of patients with poor or high expression of miR-363 using the Kaplan-Meier analysis; E, sp1 expression in GC and adjacent tissues assessed by RT-qPCR (*p < 0.05 by the paired t test); F, Person’s correlation analysis of circ0005654 and sp1 expression in GC tissues; G, Person’s correlation analysis of correlation between miR-363 and sp1; H, the predictive effect of sp1 on GC tissues evaluated by ROC curve using the Wilson/Brown analysis; I, the survival curves of patients with poor or high expression of sp1 using the Kaplan-Meier analysis